Skip to content
PubMed This is a summary of 96 peer-reviewed journal articles Updated
Endocrinology · Acromegaly

Acromegaly (Growth Hormone-Secreting Pituitary Adenoma): A Patient Guide

At a Glance

Acromegaly usually comes from a noncancerous pituitary tumor that makes too much growth hormone, raising IGF-1 over time. Surgery is often the first treatment, while medicines and ongoing monitoring can control hormones and protect the heart, joints, and metabolic health.

Acromegaly is a rare, systemic condition that occurs when the body is exposed to excessive levels of growth hormone over a long period. In the vast majority of cases, this process begins with a pituitary adenoma, a benign (non-cancerous) tumor that develops on the pituitary gland at the base of the brain [1]. This “master gland” begins to pump out growth hormone (GH) without the usual signals to stop. As this excess hormone travels through the bloodstream, it triggers the liver to produce insulin-like growth factor-1 (IGF-1), the primary driver behind the physical and metabolic changes associated with the disease [1][2].

Because the changes driven by these hormones are incredibly slow and subtle, acromegaly is often characterized by a significant diagnostic delay. Many patients spend years visiting specialists for individual symptoms—such as persistent joint pain, sleep apnea, or changes in ring and shoe size—before the underlying hormonal cause is identified [3][4]. By the time a diagnosis is confirmed, the excess hormones may have already begun to affect the internal organs, the cardiovascular system, and the structure of the bones and joints [5]. Validating this long “diagnostic odyssey” is often the first step in a patient’s emotional recovery and the beginning of a proactive management plan.

The primary goal of treatment is to safely reduce or remove the tumor and normalize hormone levels to prevent further damage to the body. For most people, the first-line treatment is surgery to remove the adenoma, which can lead to immediate relief of pressure symptoms and aims for full biochemical control [6]. If surgery is not possible or does not fully bring hormone levels into a healthy range, modern medicine offers a variety of effective medical therapies. These treatments range from monthly injections that “turn off” hormone production to medications that block growth hormone from acting on your cells, allowing your care team to tailor a plan to your specific tumor type [7].

Living with acromegaly requires a long-term partnership with a specialized medical team. Even when hormone levels are successfully controlled, the condition requires ongoing monitoring of “comorbidities”—the related health issues like thickened heart muscle (cardiomyopathy), metabolic changes, and permanent joint wear [8][9]. While some physical changes may be permanent, achieving biochemical control can significantly improve your quality of life, boost your energy, and protect your long-term health. Understanding the biology of your diagnosis is the foundation for navigating this journey with confidence and clarity.

Common questions in this guide

What causes acromegaly?
Most cases of acromegaly are caused by a benign tumor in the pituitary gland that releases too much growth hormone. The hormone prompts the liver to make IGF-1, which drives many of the condition’s gradual changes.
What symptoms can acromegaly cause?
Possible signs include gradual changes in ring, shoe, or hand size, changes in facial features, joint pain, sleep apnea, and low energy. Because these changes develop slowly, people may be diagnosed only after years of symptoms.
Is surgery usually the first treatment for acromegaly?
For many people, surgery to remove the pituitary adenoma is the first treatment and may relieve pressure symptoms while aiming to normalize hormone levels. If surgery is not possible or hormone levels remain high, additional medication may be needed.
What happens if surgery does not normalize my acromegaly hormone levels?
Your care team may recommend medicines that reduce growth hormone production, including monthly injections, or medicines that block growth hormone from acting on cells. The choice depends on your tumor and hormone results.
How are growth hormone and IGF-1 used to monitor acromegaly?
Doctors review growth hormone and IGF-1 levels together to judge whether hormone levels are controlled. They also follow symptoms and check for effects on the heart, metabolism, joints, and other organs over time.
Will acromegaly-related physical changes go away after treatment?
Some physical changes caused by acromegaly may be permanent, even when hormone levels return to a healthy range. Treatment can still improve energy and quality of life and help protect long-term health.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my tumor appear to be a candidate for surgical removal, and what are the specific goals of my first procedure?
  2. 2.If surgery doesn't fully normalize my hormone levels, what is the next step in our treatment plan?
  3. 3.How will we monitor the impact of this condition on my heart, joints, and metabolic health over the long term?
  4. 4.Can you explain how my growth hormone and IGF-1 levels will be used together to determine if my disease is well-controlled?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Acromegaly: pathogenesis, diagnosis, and management.

    Fleseriu M, Langlois F, Lim DST, et al.

    The lancet. Diabetes & endocrinology 2022; (10(11)):804-826 doi:10.1016/S2213-8587(22)00244-3.

    PMID: 36209758
  2. 2

    Consensus on criteria for acromegaly diagnosis and remission.

    Giustina A, Biermasz N, Casanueva FF, et al.

    Pituitary 2024; (27(1)):7-22 doi:10.1007/s11102-023-01360-1.

    PMID: 37923946
  3. 3

    Ends of the spectrum best practices for early detection and multidisciplinary management of acromegaly.

    Cheok SK, Tavakoli-Sabour S, Beck RT, et al.

    Journal of neuro-oncology 2025; (171(1)):1-9 doi:10.1007/s11060-024-04833-w.

    PMID: 39607571
  4. 4

    Acromegaly: clinical features at diagnosis.

    Vilar L, Vilar CF, Lyra R, et al.

    Pituitary 2017; (20(1)):22-32 doi:10.1007/s11102-016-0772-8.

    PMID: 27812777
  5. 5

    A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.

    Giustina A, Barkan A, Beckers A, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(4)) doi:10.1210/clinem/dgz096.

    PMID: 31606735
  6. 6

    Diagnosis and Treatment of Acromegaly: An Update.

    Ershadinia N, Tritos NA

    Mayo Clinic proceedings 2022; (97(2)):333-346 doi:10.1016/j.mayocp.2021.11.007.

    PMID: 35120696
  7. 7

    A Pituitary Society update to acromegaly management guidelines.

    Fleseriu M, Biller BMK, Freda PU, et al.

    Pituitary 2021; (24(1)):1-13 doi:10.1007/s11102-020-01091-7.

    PMID: 33079318
  8. 8

    The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study.

    De Alcubierre D, Feola T, Cozzolino A, et al.

    Pituitary 2024; (27(4)):416-427 doi:10.1007/s11102-024-01403-1.

    PMID: 38847918
  9. 9

    Clinical and radiographic assessment of peripheral joints in controlled acromegaly.

    Pelsma ICM, Kroon HM, van Trigt VR, et al.

    Pituitary 2022; (25(4)):622-635 doi:10.1007/s11102-022-01233-z.

    PMID: 35726113

This page explains acromegaly, pituitary adenoma treatment, and long-term monitoring for informational purposes only and does not constitute medical advice. Your endocrinology and surgical team can interpret your hormone results and recommend care for your specific situation.

Get notified when new evidence is published on growth hormone-producing pituitary gland neoplasm.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.